Advertisement
Screener

ATARA BIOTHERAPEUTICS, INC. (ATRA) Net Margin

ATARA BIOTHERAPEUTICS, INC. (ATRA) Net Margin

  • 2026-06-30: Net Margin -767.30%.
  • 2026-03-31: Net Margin -803.29%.
  • 2025-12-31: Net Margin -213.54%.
  • 2025-09-30: Net Margin -124.62%.

Complete source-backed net margin history.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-767.30%
2026-03-31-803.29%
2025-12-31-213.54%
2025-09-30-124.62%
2025-06-3013.58%
2025-03-3138.73%
2024-12-31-38.75%
2024-09-30-54.51%
2024-06-30-66.51%
2024-03-31-116.07%
2023-12-31-1421.68%
2023-09-30-3264.59%
2023-06-30-7430.30%
2023-03-31-6098.78%
2022-12-31-33742.99%
2022-09-30-1885.87%
2022-06-3035.80%
2022-03-31-1204.61%

Annual Net Margin

DateNet Margin
2025-12-3127.07%
2024-12-31-66.23%
2023-12-31-3220.88%
2022-12-31-359.12%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Vaxart, Inc. (VXRT)United States$0.080B3.84
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37